A quadruple whammy of viruses – flu, COVID, norovirus, and respiratory syncytial virus, or RSV – is hitting the U.S. as the year comes to a close. The Centers for Disease Control and Prevention has ...

The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...

Common and highly contagious illnesses are reaching several-month highs. Norovirus has almost reached a several-year record.

National Cancer Institute researchers have developed a method called HORNET for characterizing 3D topological structures of large and flexible RNA molecules. Scientists used atomic force microscopy ...

Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...

RSV is "a common respiratory virus that infects the nose, throat, and lungs. RSV symptoms make it difficult to distinguish it ...

Zelpultide alfa is under clinical development by Airway Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs. According to the ...

Vaccine Availability and Accessibility: Vaccines are distributed and administered through a network of healthcare facilities, including public health centers and private clinics. Ensuring ...

Does it feel like almost everyone you know is sick right now? Here’s what’s going around -- and how to avoid catching it.

Respiratory syncytial virus (RSV) infections can lead to serious complications, particularly in infants and older adults aged ...

Learn why antibiotics are not effective against influenza, and what better options exist for preventing and treating the flu.